Maternus-Kliniken Past Earnings Performance
Past criteria checks 0/6
Maternus-Kliniken's earnings have been declining at an average annual rate of -22.5%, while the Healthcare industry saw earnings declining at 1.2% annually. Revenues have been declining at an average rate of 3.3% per year.
Key information
-22.5%
Earnings growth rate
-22.7%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | -3.3% |
Return on equity | n/a |
Net Margin | -12.4% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 05A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price
Mar 13Maternus-Kliniken (ETR:MAK) Will Be Hoping To Turn Its Returns On Capital Around
Jul 27The Returns On Capital At Maternus-Kliniken (ETR:MAK) Don't Inspire Confidence
Feb 22Some Investors May Be Worried About Maternus-Kliniken's (ETR:MAK) Returns On Capital
Jul 27Estimating The Fair Value Of Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Jun 10Revenue & Expenses Breakdown
How Maternus-Kliniken makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 115 | -14 | 0 | 0 |
30 Sep 23 | 113 | -17 | 0 | 0 |
30 Jun 23 | 102 | -19 | 0 | 0 |
31 Mar 23 | 105 | -16 | 0 | 0 |
31 Dec 22 | 107 | -14 | 0 | 0 |
30 Sep 22 | 108 | -10 | 0 | 0 |
30 Jun 22 | 110 | -6 | 0 | 0 |
31 Mar 22 | 111 | -4 | 0 | 0 |
31 Dec 21 | 111 | -3 | 0 | 0 |
30 Sep 21 | 114 | -5 | 0 | 0 |
30 Jun 21 | 116 | -7 | 0 | 0 |
31 Mar 21 | 115 | -8 | 0 | 0 |
31 Dec 20 | 114 | -10 | 0 | 0 |
30 Sep 20 | 116 | -10 | 1 | 0 |
30 Jun 20 | 117 | -10 | 2 | 0 |
31 Mar 20 | 121 | -10 | 3 | 0 |
31 Dec 19 | 124 | -10 | 5 | 0 |
30 Sep 19 | 125 | -7 | 6 | 0 |
30 Jun 19 | 125 | -5 | 8 | 0 |
31 Mar 19 | 125 | -3 | 11 | 0 |
31 Dec 18 | 124 | -2 | 13 | 0 |
30 Sep 18 | 125 | -2 | 17 | 0 |
30 Jun 18 | 126 | -2 | 21 | 0 |
31 Mar 18 | 126 | -2 | 17 | 0 |
31 Dec 17 | 127 | -1 | 14 | 0 |
30 Sep 17 | 127 | 0 | 14 | 0 |
30 Jun 17 | 126 | 2 | 14 | 0 |
31 Mar 17 | 125 | 1 | 14 | 0 |
31 Dec 16 | 124 | 1 | 14 | 0 |
30 Sep 16 | 124 | 4 | 21 | 0 |
30 Jun 16 | 124 | 2 | 14 | 0 |
31 Mar 16 | 124 | 2 | 14 | 0 |
31 Dec 15 | 123 | 2 | 14 | 0 |
30 Sep 15 | 123 | 28 | 14 | 0 |
30 Jun 15 | 124 | 28 | 14 | 0 |
31 Mar 15 | 123 | 28 | 14 | 0 |
31 Dec 14 | 122 | 27 | 14 | 0 |
30 Sep 14 | 120 | -9 | 15 | 0 |
30 Jun 14 | 118 | -10 | 15 | 0 |
31 Mar 14 | 115 | -11 | 15 | 0 |
31 Dec 13 | 114 | -13 | 15 | 0 |
30 Sep 13 | 113 | -12 | 15 | 0 |
Quality Earnings: MAK is currently unprofitable.
Growing Profit Margin: MAK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MAK is unprofitable, and losses have increased over the past 5 years at a rate of 22.5% per year.
Accelerating Growth: Unable to compare MAK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MAK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-2.2%).
Return on Equity
High ROE: MAK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.